申请人:SMB Innovation
                            
                            
                                公开号:US20140329854A1
                            
                            
                                公开(公告)日:2014-11-06
                            
                            Provided are novel heterocyclic sirtuin binding agents, e.g., N-aryl substituted pyridine dicarboxamides, which are useful as sirtuin modulators. Also provided are methods of using the pyridine dicarboxamide compounds for treating sirtuin mediated disorders and conditions, such as diabetes, cancers, and obesity and diseases related to aging.